DeckTherapeutics today announced the formation of a Scientific Advisory Board comprised of some of the world’s foremost clinician scientists, practitioners and clinical trial experts, in the area of treating hypoxic-ischemic brain injuries.
DeckTherapeutics announces the formation of Scientific Advisory Board
Previous
Previous
DeckTherapeutics announces grant of patent
Next
Next